Eargo's last flagship offering, the Eargo 8. LXE Hearing, the company formed through the 2025 merger of Eargo and hearX, has begun winding down its U.S. operations, according to notices posted on the Eargo, Lexie Hearing, and LXE Hearing websites. The nearly identical notices say Eargo and Lexie hearing aids will continue providing amplification and their core functions....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change to clinical practice, but audiologists should be prepared for patients with Eargo or Lexie devices to seek alternative support and care as LXE Hearing winds down U.S. operations.
The collapse of a major direct-to-consumer hearing aid company affects thousands of existing device users and signals continued fragility in the OTC and DTC hearing aid market.
- 01LXE Hearing (parent of Eargo and Lexie) has begun winding down U.S. operations.
- 02LXE was formed from the 2025 merger of Eargo and hearX.
- 03Customer support for existing device users is uncertain beyond September 15.
- 04The wind-down affects both Eargo and Lexie brand hearing aid customers.
- 05This represents a significant contraction in the direct-to-consumer hearing aid segment.
LXE Hearing has begun winding down its U.S. operations with customer support uncertain beyond September 15.
press releasesupported
